<p>Changes between T2 and T1 as mean (SD), in the whole group and separately in LVAD and HTx patients.</p
<p>Dynamic change of ET-1 in the serum from the three groups (mean±SD, ng/L).</p
<p>Clinical variables for all responding patients from the different wards at T0 and T1 respectively...
<p>Data are presented as mean and SD (in ascending order from left to right based on their mean valu...
Lipids changes during therapy in subgroups according to the prior TDF intake.</p
<p>* and bold font indicates significant difference. L = left, R = right.</p><p>Group mean values fo...
<p>Mean test scores (SD) and effect sizes for group differences (absolute values) for patients that ...
Individual change between performances at T2 and T0 for all outcome measures.</p
<p>Dynamic change of TGF-β1 in the lungs of the three groups (mean±SD, ng/L).</p
<p>Changes in patient medication adherence and social functioning (T0, T1 and T2 comparison).</p
Mean (SD) values of the SC features of the MDD patients and the healthy controls during P1-P5.</p
<p>Changes (values after RAGT-values before RAGT) in variables for all patients and for the three di...
<p>Within group changes in medical outcomes over time and between-group differences.</p
<p>Mean changes in the total scores and in the three domains in ambulant and non ambulant patients.<...
<p>Changes of serum glucose level of different groups at different time-scales.</p
<p>Subgroup Analyses for the mean difference of HbA1c in the pharmacist intervention compared with u...
<p>Dynamic change of ET-1 in the serum from the three groups (mean±SD, ng/L).</p
<p>Clinical variables for all responding patients from the different wards at T0 and T1 respectively...
<p>Data are presented as mean and SD (in ascending order from left to right based on their mean valu...
Lipids changes during therapy in subgroups according to the prior TDF intake.</p
<p>* and bold font indicates significant difference. L = left, R = right.</p><p>Group mean values fo...
<p>Mean test scores (SD) and effect sizes for group differences (absolute values) for patients that ...
Individual change between performances at T2 and T0 for all outcome measures.</p
<p>Dynamic change of TGF-β1 in the lungs of the three groups (mean±SD, ng/L).</p
<p>Changes in patient medication adherence and social functioning (T0, T1 and T2 comparison).</p
Mean (SD) values of the SC features of the MDD patients and the healthy controls during P1-P5.</p
<p>Changes (values after RAGT-values before RAGT) in variables for all patients and for the three di...
<p>Within group changes in medical outcomes over time and between-group differences.</p
<p>Mean changes in the total scores and in the three domains in ambulant and non ambulant patients.<...
<p>Changes of serum glucose level of different groups at different time-scales.</p
<p>Subgroup Analyses for the mean difference of HbA1c in the pharmacist intervention compared with u...
<p>Dynamic change of ET-1 in the serum from the three groups (mean±SD, ng/L).</p
<p>Clinical variables for all responding patients from the different wards at T0 and T1 respectively...
<p>Data are presented as mean and SD (in ascending order from left to right based on their mean valu...
DOI
Add to ORKG